Israel Englander Imara Inc. Transaction History

Millennium Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.99 - $1.87 $10,203 - $19,274	-10,307 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.15 - $2.41 $70,774 - $148,318	-61,543 Reduced 85.65%	10,307 $19,000
Q4 2021 Feb 14, 2022	SELL	$2.25 - $4.05 $71,894 - $129,409	-31,953 Reduced 30.78%	71,850 $162,000
Q3 2021 Nov 15, 2021	BUY	$4.08 - $7.83 $281,275 - $539,800	68,940 Added 197.75%	103,803 $424,000
Q2 2021 Aug 16, 2021	BUY	$6.78 - $9.04 $117,171 - $156,229	17,282 Added 98.3%	34,863 $275,000
Q1 2021 May 17, 2021	BUY	$8.18 - $23.98 $147 - $431	18 Added 0.1%	17,581 $148,000
Q4 2020 Feb 16, 2021	BUY	$15.81 - $29.0 $277,671 - $509,327	17,563 New	17,563 $387,000
Q3 2020 Nov 16, 2020	SELL	$18.75 - $28.58 $207,600 - $316,437	-11,072 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$15.6 - $54.87 $172,723 - $607,520	11,072 New	11,072 $306,000

104K

170K

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.